Engineering the Melanocortin-4 Receptor for Gs Signaling Control
Author Information
Author(s): Srinivasan Supriya, Santiago Pamela, Lubrano Cecile, Vaisse Christian, Conklin Bruce R.
Primary Institution: University of California at San Francisco
Hypothesis
Can engineered melanocortin-4 receptors (RASSLs) control Gs signaling in vivo?
Conclusion
The study successfully developed two engineered receptors that can selectively activate Gs signaling without responding to endogenous ligands.
Supporting Evidence
- Two engineered receptors were developed that respond to a synthetic ligand.
- These receptors can activate Gs signaling in any tissue, aiding body weight regulation studies.
- The study highlights the potential of using human genetic variations for protein engineering.
Takeaway
Scientists created special receptors that can be turned on by a synthetic drug to help study how they control body weight without being affected by natural hormones.
Methodology
The study involved cloning, mutagenesis, and testing receptor activity in HEK293 cells using cAMP assays.
Limitations
The study primarily focused on in vitro experiments, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website